RankAlpha logo
Back to Rankings

AZN

AstraZenecaF
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
AZN vs peer average
15/100
AZN vs. peer average (F vs. B)
Grade spread
A 1 · B 3 · C 6
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

BMY is the first available peer comparator.

Oncology-focused peer with similar pipeline-driven growth dynamics and M&A activity.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerBMYBristol-Myers Squibb
AZN
AstraZeneca
BMY
Bristol-Myers Squibb
Grade
F
C
Momentum
35
43
Value
62
70
Sentiment
5
51
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Defensive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs BMY

AZN / BMY
Grade Position
Below peers
AZN vs. peer average (F vs. B)
15/100
Momentum
35
BMY
Value
62
BMY
Sentiment
5
BMY

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs AZN
1
BMY
BMY
C
60/100
-2
2
JNJ
JNJ
C
60/100
-2
3
PFE
PFE
C
60/100
-2
4
MRK
Merck & Co Inc Common
B
80/100
-3
5
NVS
Novartis AG ADR
C
60/100
-2
BMY is the first peer returned for this comparison set.